Muromonab-Cd3 vs Tofacitinib
Muromonab-Cd3 vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Muromonab-Cd3 and Tofacitinib.
Mechanism of Action
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Tofacitinib — 3.2 hours.
Chemical Properties
Molecular Formula: Tofacitinib — C16H20N6O.
Molecular Weight: Tofacitinib — 312.3700 g/mol.
Type: Muromonab-Cd3 — Unknown; Tofacitinib — Small molecule.